1. Home
  2. MEDP vs ALGN Comparison

MEDP vs ALGN Comparison

Compare MEDP & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$572.21

Market Cap

13.4B

Sector

Health Care

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$158.25

Market Cap

11.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEDP
ALGN
Founded
1992
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4B
11.9B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
MEDP
ALGN
Price
$572.21
$158.25
Analyst Decision
Hold
Buy
Analyst Count
12
13
Target Price
$468.82
$187.50
AVG Volume (30 Days)
243.4K
1.2M
Earning Date
02-09-2026
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
25.36
N/A
EPS
14.32
5.16
Revenue
$2,358,373,000.00
$3,982,622,000.00
Revenue This Year
$21.43
$2.58
Revenue Next Year
$11.99
$3.36
P/E Ratio
$39.72
$30.63
Revenue Growth
13.88
0.56
52 Week Low
$250.05
$122.00
52 Week High
$626.26
$237.23

Technical Indicators

Market Signals
Indicator
MEDP
ALGN
Relative Strength Index (RSI) 51.85 57.28
Support Level $561.83 $154.98
Resistance Level $577.40 $159.16
Average True Range (ATR) 11.59 3.52
MACD 1.40 -1.19
Stochastic Oscillator 82.06 24.75

Price Performance

Historical Comparison
MEDP
ALGN

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: